goralatide has been researched along with rxpa380 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beau, F; Cotton, J; Czarny, B; Dive, V; Georgiadis, D; Yiotakis, A | 1 |
1 other study(ies) available for goralatide and rxpa380
Article | Year |
---|---|
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Substrate Specificity | 2003 |